Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Merck Patent discloses new fatty acid synthase inhibitors

March 2, 2015

Merck & Co. patents new ROMK channel blockers

Feb. 24, 2015

New guanylyl cyclase activators disclosed by Bayer

Feb. 24, 2015

FDA grants orphan drug status to polidocanol for venous malformations

Feb. 23, 2015

Tambocor fine granules approved in Japan for pediatric patients

Feb. 20, 2015

Novartis's LCZ-696 to receive FDA priority review for heart failure

Feb. 16, 2015

Novartis reports new apelin receptor agonists

Feb. 16, 2015

Bayer Schering Pharma reports dual sGC activators/PDE5 inhibitors

Feb. 6, 2015

Mast Therapeutics begins phase IIa studies of AIR-001 in heart failure

Feb. 6, 2015

Trevena presents an innovative composite endpoint for BLAST-AHF trial

Feb. 6, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...